DY6
0.135
92.9%
EEL
0.001
-50%
LKY
0.042
82.6%
HCF
0.02
-44.4%
DTR
0.036
63.6%
DTM
0.003
-40%
DES
0.165
57.1%
MTB
0.003
-40%
HRE
0.029
52.6%
DYM
0.215
-34.8%
TMK
0.003
50%
JAV
0.002
-33.3%
WCN
0.034
47.8%
MIO
0.018
-33.3%
AZL
0.01
42.9%
VFX
0.002
-33.3%
YAR
0.007
40%
ANX
0.007
-30%
VRX
0.057
39%
IFG
0.005
-28.6%
WJL
0.895
37.7%
HLS
1.155
-26.2%
CMD
0.022
37.5%
XPN
0.015
-25%
VRL
0.022
37.5%
C29
0.035
-23.9%
BCB
0.475
33.8%
BB1
0.32
-21%
CRB
0.004
33.3%
1AD
0.004
-20%
GGE
0.004
33.3%
AVE
0.004
-20%
OSL
0.004
33.3%
PUR
0.037
-19.6%
PPY
0.012
33.3%
OPL
0.021
-19.2%
THB
0.012
33.3%
NWM
0.013
-18.8%
VEN
0.004
33.3%
EV1
0.009
-18.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Control Bionics (ASX:CBL): Expands global reach with exclusive UK and Ireland distribution agreement

Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.

• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.

Jeremy Steele, CEO of Control Bionics, commented: “The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world.”

Read the ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20240909/pdf/067np1hzgg2sbv.pdf

Write to us
  • © 2025 Copyright
  • The Stock Network
  • All rights reserved